國脈科技(002093.SZ):擬終止“國脈雲健康醫學中心”項目
格隆匯4月22日丨國脈科技(002093.SZ)公佈,公司原募集資金項目“國脈雲健康醫學中心”,因醫生“多點執業”政策執行未達預期、專業醫療團隊引進受阻、互聯網醫療政策推進和技術條件限制,公司根據目前該項目的實際進展情況,結合公司發展規劃和內外部環境等因素,為了避免項目投資風險,保護中小投資者利益,提高募集資金使用效益,公司擬終止“國脈雲健康醫學中心”項目,項目終止後募集資金投資項目的節餘募集資金(包含募集資金本金、現金管理收益及存款利息)繼續存放於募集資金專户或進行現金管理。
截至公告日公司已用於現金管理的募集資金5億元,將在到期日後連同本金及收益轉回至募集資金專户。對節餘募集資金(包含募集資金本金、現金管理收益及存款利息)的後續使用及安排,公司儘快、合理地進行決策並將嚴格履行相關法定程序。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.